These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23355135)

  • 21. [Primary and secondary prevention of sudden cardiac death].
    Janion M; Sadowski M; Sielski J; Janion-Sadowska A
    Pol Arch Med Wewn; 2006 Jan; 115(1):65-72. PubMed ID: 17278788
    [No Abstract]   [Full Text] [Related]  

  • 22. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
    Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
    Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 24. Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now?
    Al-Khatib SM; Gillis AM; Curtis AB
    Circulation; 2018 Jan; 137(4):317-319. PubMed ID: 29070501
    [No Abstract]   [Full Text] [Related]  

  • 25. Do traditional VT zones improve outcome in primary prevention ICD patients?
    Duncan E; Thomas G; Johns N; Pfeffer C; Appanna G; Shah N; Hunter R; Finlay M; Schilling RJ; Sporton S
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1353-8. PubMed ID: 20727095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
    Gerstenfeld EP
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
    [No Abstract]   [Full Text] [Related]  

  • 28. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
    Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac metastasis causing right bundle branch block and recurrent septal ventricular tachycardia.
    Badri M; Bradley J; Ju R; Yan GX
    J Cardiovasc Electrophysiol; 2014 Jul; 25(7):793-4. PubMed ID: 24612005
    [No Abstract]   [Full Text] [Related]  

  • 33. Current concepts in electrical defibrillation.
    Truong JH; Rosen P
    J Emerg Med; 1997; 15(3):331-8. PubMed ID: 9258783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B; Kühne M; Reichlin T; Osswald S; Sticherling C
    Europace; 2016 Feb; 18(2):227-31. PubMed ID: 26063686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
    Patel C; Yan GX; Kocovic D; Kowey PR
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
    [No Abstract]   [Full Text] [Related]  

  • 36. Transvenous ICD lead malposition in the left ventricle: long-term follow-up.
    Franck H; Wollschläger H
    Clin Res Cardiol; 2013 Feb; 102(2):159-61. PubMed ID: 22868694
    [No Abstract]   [Full Text] [Related]  

  • 37. Noninvasive imaging markers associated with sudden cardiac death.
    van der Bijl P; Delgado V; Bax JJ
    Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report: Cardiac sarcoidosis presenting with ventricular arrhythmias: case report and review of the literature.
    Mori M; Hanon S; Rachko M
    Int J Cardiol; 2007 Aug; 120(2):e21-3. PubMed ID: 17588690
    [No Abstract]   [Full Text] [Related]  

  • 39. Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.
    Volosin KJ; Exner DV; Wathen MS; Sherfesee L; Scinicariello AP; Gillberg JM
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):280-9. PubMed ID: 20958831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The implantable cardioverter-defibrillator: An update.
    Miller JD; Yousuf O; Berger RD
    Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.